These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19619258)

  • 61. Natural course of extrahepatic nonmalignant partial portal vein thrombosis in patients with cirrhosis.
    Luca A; Caruso S; Milazzo M; Marrone G; Mamone G; Crinò F; Maruzzelli L; Miraglia R; Floridia G; Vizzini G
    Radiology; 2012 Oct; 265(1):124-32. PubMed ID: 22891357
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Portal Vein Thrombosis Is a Risk Factor for Poor Early Outcomes After Liver Transplantation: Analysis of Risk Factors and Outcomes for Portal Vein Thrombosis in Waitlisted Patients.
    Ghabril M; Agarwal S; Lacerda M; Chalasani N; Kwo P; Tector AJ
    Transplantation; 2016 Jan; 100(1):126-33. PubMed ID: 26050013
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A Preclinical Porcine Model of Portal Vein Thrombosis in Liver Cirrhosis.
    Zhang R; Lu S; Jiang YY; Ma JQ; Zhang W; Gu JY; Wang J; Chen SY
    Biomed Res Int; 2020; 2020():3086906. PubMed ID: 32351989
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Significance of altered anticoagulant proteins and D-dimer in cirrhotic portal vein thrombosis: relation to the degree of liver dysfunction.
    Metawea M; El Wazzan D; El-Shendidi A
    Clin Exp Hepatol; 2022 Sep; 8(3):233-242. PubMed ID: 36685270
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Platelet-derived TGF-β1 is related to portal vein thrombosis in cirrhosis by promoting hypercoagulability and endothelial dysfunction.
    Jiang S; Ai Y; Ni L; Wu L; Huang X; Chen S
    Front Cardiovasc Med; 2022; 9():938397. PubMed ID: 36225950
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis: results of a longitudinal study.
    Nery F; Chevret S; Condat B; de Raucourt E; Boudaoud L; Rautou PE; Plessier A; Roulot D; Chaffaut C; Bourcier V; Trinchet JC; Valla DC;
    Hepatology; 2015 Feb; 61(2):660-7. PubMed ID: 25284616
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Potential contribution of the gut microbiota to the development of portal vein thrombosis in liver cirrhosis.
    Huang XY; Zhang YH; Yi SY; Lei L; Ma T; Huang R; Yang L; Li ZM; Zhang D
    Front Microbiol; 2023; 14():1217338. PubMed ID: 37965548
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinical Impact and Safety of Anticoagulants for Portal Vein Thrombosis in Cirrhosis.
    Pettinari I; Vukotic R; Stefanescu H; Pecorelli A; Morelli M; Grigoras C; Sparchez Z; Andreone P; Piscaglia F;
    Am J Gastroenterol; 2019 Feb; 114(2):258-266. PubMed ID: 30538290
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Risk factors for portal venous thrombosis after splenectomy in patients with cirrhosis and portal hypertension.
    Kinjo N; Kawanaka H; Akahoshi T; Tomikawa M; Yamashita N; Konishi K; Tanoue K; Shirabe K; Hashizume M; Maehara Y
    Br J Surg; 2010 Jun; 97(6):910-6. PubMed ID: 20474001
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Portal vein thrombosis is not associated with increased mortality among patients with cirrhosis.
    Berry K; Taylor J; Liou IW; Ioannou GN
    Clin Gastroenterol Hepatol; 2015 Mar; 13(3):585-93. PubMed ID: 25459555
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Value of D-dimer and protein S for diagnosis of portal vein thrombosis in patients with liver cirrhosis.
    Zhang DL; Hao JY; Yang N
    J Int Med Res; 2013 Jun; 41(3):664-72. PubMed ID: 23637275
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Efficacy and safety of anticoagulation therapy with different doses of enoxaparin for portal vein thrombosis in cirrhotic patients with hepatitis B.
    Cui SB; Shu RH; Yan SP; Wu H; Chen Y; Wang L; Zhu Q
    Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):914-9. PubMed ID: 25856686
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Therapeutic and clinical aspects of portal vein thrombosis in patients with cirrhosis.
    Primignani M; Tosetti G; La Mura V
    World J Hepatol; 2015 Dec; 7(29):2906-12. PubMed ID: 26689354
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Management and long-term consequences of portal vein thrombosis after liver transplantation in children.
    Jensen MK; Campbell KM; Alonso MH; Nathan JD; Ryckman FC; Tiao GM
    Liver Transpl; 2013 Mar; 19(3):315-21. PubMed ID: 23495080
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A prediction model for successful anticoagulation in cirrhotic portal vein thrombosis.
    Rodriguez-Castro KI; Vitale A; Fadin M; Shalaby S; Zerbinati P; Sartori MT; Landi S; Pettinari I; Piscaglia F; Han G; Burra P; Simioni P; Senzolo M
    Eur J Gastroenterol Hepatol; 2019 Jan; 31(1):34-42. PubMed ID: 30188408
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Portal vein thrombosis after splenectomy in pediatric hematologic disease: risk factors, clinical features, and outcome.
    Soyer T; Ciftci AO; Tanyel FC; Senocak ME; Büyükpamukçu N
    J Pediatr Surg; 2006 Nov; 41(11):1899-902. PubMed ID: 17101367
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Hyperhomocysteinemia and MTHFR C677T polymorphism in patients with portal vein thrombosis complicating liver cirrhosis.
    Ventura P; Venturelli G; Marcacci M; Fiorini M; Marchini S; Cuoghi C; Pietrangelo A
    Thromb Res; 2016 May; 141():189-95. PubMed ID: 27065203
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clinical significance of small-bowel villous edema in patients with liver cirrhosis: A capsule endoscopy study.
    Otani I; Oka S; Tanaka S; Tsuboi A; Kunihara S; Nagaoki Y; Aikata H; Chayama K
    J Gastroenterol Hepatol; 2018 Apr; 33(4):825-830. PubMed ID: 29023961
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Evaluation of 4D Flow MRI-Derived Relative Residence Time as a Marker for Cirrhosis Associated Portal Vein Thrombosis.
    Hyodo R; Takehara Y; Ishizu Y; Nishida K; Mizuno T; Ichikawa K; Horiguchi R; Kurata N; Ogura Y; Yokoyama S; Naganawa S; Jin N; Ichiba Y
    J Magn Reson Imaging; 2024 Mar; ():. PubMed ID: 38490816
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Current status of portal vein thrombosis in Japan: Results of a questionnaire survey by the Japan Society for Portal Hypertension.
    Kojima S; Watanabe N; Koizumi J; Kokubu S; Murashima N; Matsutani S; Obara K
    Hepatol Res; 2018 Mar; 48(4):244-254. PubMed ID: 28902450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.